Bio-Techne, Progen launch Simple Plex AAV2 immunoassay

By The Science Advisory Board staff writers

July 28, 2021 -- Bio-Techne and Progen have launched the Simple Plex adeno-associated virus 2 (AAV2) viral titer assay for AAV2 total capsid quantification.

The assay combines the scalability and automation of the Ella platform with AAV reagents from Progen, according to Bio-Techne. It features hands-free automation and utilizes Progen's recombinant AAV2 antibody (A20R) to quantify assembled AAV2 capsids. Also, the assay is designed to minimize variability and ensure optimum and consistent quantitation throughout the viral purification process, the company noted.


Copyright © 2021 scienceboard.net
 


Email Address:

First Name:

Last Name:

Learn about ScienceBoard

Get the latest life sciences research and industry news, delivered straight to your inbox, for free.

Why subscribe?

ScienceBoard is uniquely focused on the business of research, addressing the biggest problems that the biomedical industry face. You’ll get breaking news, events coverage, and deep dives into the science that drives innovation, delivered to your inbox daily.

I have read and agree to the privacy policy and terms of service and wish to opt-in for ScienceBoard.net.